Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
The Lancet. Oncology|January 21, 2014
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trialStefan Aebi, Shari Gelber, Stewart J Anderson, et al.NEJM Evidence|February 6, 2024
Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy SurgeryBarbara L Smith, Kelly K Hunt, David Carr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105Melinda L Telli, Kristin C Jensen, Shaveta Vinayak, et al.JAMA Surgery|July 1, 2026
Lumpectomy Margins and Local Recurrence in DCIS: Results From the NRG Oncology/NSABP B-35 Randomized Clinical TrialIrene L Wapnir, Reena S Cecchini, James J Dignam, et al.JAMA Surgery|May 7, 2025
Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical TrialMark Basik, Reena S Cecchini, Jennifer F De Los Santos, et al.The Journal of Experimental Medicine|June 20, 2020
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trialMatthew J Frank, Michael S Khodadoust, Debra K Czerwinski, et al.The New England Journal of Medicine|December 6, 2018
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast CancerGunter von Minckwitz, Chiun-Sheng Huang, Max S Mano, et al.Annals of Surgical Oncology|October 6, 2016
Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In SituJennifer B Manders, Henry M Kuerer, Benjamin D Smith, et al.Journal of the National Cancer Institute|November 9, 2014
Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer researchMartine Moossdorff, Lori M van Roozendaal, Luc J A Strobbe, et al.The New England Journal of Medicine|January 15, 2025
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast CancerCharles E Geyer, Michael Untch, Chiun-Sheng Huang, et al.Pageof 6